Pallas Capital Advisors
GILD icon

Pallas Capital Advisors’s Gilead Sciences GILD Stock Holding History

Pallas Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$940K Sell
7,440
-118
-2% -$15.5K 0.03% 373
2026
Q1 		$1.05M Sell
7,558
-1,379
-15% -$193K 0.04% 318
2025
Q4 		$1.1M Buy
8,937
+91
+1% +$11.1K 0.04% 341
2025
Q3 		$982K Buy
8,846
+137
+2% +$15.6K 0.04% 350
2025
Q2 		$966K Buy
8,709
+869
+11% +$92.5K 0.04% 339
2025
Q1 		$878K Sell
7,840
-310
-4% -$32K 0.04% 321
2024
Q4 		$753K Buy
8,150
+314
+4% +$28.3K 0.03% 294
2024
Q3 		$696K Buy
7,836
+2,069
+36% +$158K 0.03% 293
2024
Q2 		$424K Buy
5,767
+2,665
+86% +$178K 0.02% 342
2024
Q1 		$227K Buy
+3,102
New +$239K 0.01% 395

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pallas Capital Advisors's GILD Position: Q2 2026 in Review

Pallas Capital Advisors reduced its Gilead Sciences (GILD) stake by 1.6% in Q2 2026, selling an estimated $15.5K and leaving 7,440 shares worth $940K. The position accounts for 0.03% of the portfolio, ranked #373.

Pallas Capital Advisors first reported a position in GILD in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.1M in Q4 2025. 2,292 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Pallas Capital Advisors held 7,440 shares of Gilead Sciences worth $940K as of Q2 2026.
  • Pallas Capital Advisors sold 118 Gilead Sciences shares in Q2 2026, an estimated $15.5K.
  • Gilead Sciences made up 0.03% of Pallas Capital Advisors's portfolio in Q2 2026, its #373 holding.
  • Pallas Capital Advisors first reported a position in Gilead Sciences in Q1 2024 and has held it in 10 quarters since.
  • Pallas Capital Advisors's Gilead Sciences position peaked at $1.1M in Q4 2025.
  • 2,292 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.